ISSN: 2641-1725
Manuel Carballo*
Received: January 30, 2020; Published: February 04, 2020
*Corresponding author: Manuel Carballo, Executive Director, ICMHD, 11 Route du Nant d’Avril 1214, Geneva, Switzerland
DOI: 10.32474/LOJMS.2020.04.000193
The decade we have just embarked on is likely to be replete
with medical breakthroughs that could revolutionize our capacity
to diagnose, treat and possibly prevent many of the diseases that
have plagued the world for centuries. The coming ten years are
also likely to witness socio-demographic transitions of a magnitude
that have not been seen before. Some of them have been underway
for many years, others are still emerging. All of them are likely to
accelerate massively in the coming ten years and present the world
with new and possibly difficult-to-meet public health challenges.
Conservative estimates place the global number of migrants
crossing borders in search of work at about 258 million. UNHCR,
meanwhile, reports a record number of around 71 million people
who have been uprooted and forced to flee wars and persecution
around the world; 26 million of them are refugees who have
managed to find temporary safety in other countries; another 41
million have fled to other parts of their own countries as internally
displaced people. The pace of migration from rural areas to poorly
planned, already overwhelmed and unhealthy cities in developing
countries is difficult to quantify with precision, but in China alone,
official statistics indicate that in 2018 as many as 3.4 million people
left the countryside every month to seek work in coastal cities. A
similar pace, if not size, of movement has been reported in India
and other parts of Asia as well as in Africa and Latin America where
rural poverty is pushing people to leave while the hope of a better
quality of life in mythical cities is providing the “pull”. At the same
time, vastly improved transportation and greater leisure time has
given rise to a global tourist industry that in 2018 encouraged 1.4
billion people to move around the world for recreational purposes
and at a speed never before possible. Moreover, in many parts of the
world climatic changes are now expected to displace at least 200
million people by 2050. Where they will go is not clear; movement
to cities in their own countries is likely to occur in the first instance,
but large-scale cross-border and cross-oceanic movement is soon
expected to follow once domestic employment options fail.
Because people are today moving over increasingly vast
distances, crossing ecological zones, and as in the case of refugees
and irregular migrants, doing so under difficult socioeconomic
and health conditions, they will risk being exposed to new disease
challenges they will not have had reason or time to develop herd
immunity to. In this dynamic relationship, people on the move
will be equally capable of exposing people they come into contact
with along the way to health challenges that transit hosts are also
biologically unprepared for. This potential for adverse biomedical
exchanges will continue to persist in the destinations migrants and
refugees eventually settle in and that millions of tourists regularly
leave and return to.
People move with the medical histories they have grown up
with or have gone on to acquire along their migration route. This
means the global socio-demographic shift that is already underway
and is likely to quicken, may well produce profound changes in
the distribution of both communicable and non-communicable
diseases. In some cases, these changes will be abetted by changing
ambient temperatures, altered rainfall patterns and adaptations
to these changes by local ecological systems. People will not only
move with their medical histories, however. They will also take
with them their health belief systems, their traditional knowledge
and their culturally determined attitudes to disease prevention and
health care. All of these will present new challenges for healthcare
systems along the way and in final destination societies, especially
if and where there has been no preparation for mass migration and
its potential effect on public health and clinical medicine.
The knowledge that people on the move have the capacity to
introduce new diseases is not recent. As early as the 14th century, in
response to the Black Death (bubonic disease) epidemic, port cities
such as Venice and Ragusa (now Dubrovnik) introduced regulations
designed to keep suspect ships “off-shore” for a period of forty days
during which time it was estimated that cases of bubonic plague
would incubate, present and lead to the death that was almost inevitable at the time. These measures were quickly followed
by the creation of lazarets on off-shore islands where infected
people could be accommodated and cared for. The forty day offshore
requirement eventually went on to be the basis for today’s
quarantine system. To what extent empirical epidemiologic data
were available and used by health authorities in the 14th century
in designing these quarantine responses is not clear, but today we
know that bubonic plague was not the only disease being moved
around the world by people on the move. Smallpox, syphilis, yellow
fever, tuberculosis, cholera and other communicable diseases were
all, at different moments in history, moved around the world by a
mix of explorers, settlers, military personnel, traders and pilgrims.
In the coming decade the number of people who will move,
the distances they will cover, the ecological zones they will pass
through and the speed with which they will travel will increase
significantly. With that acceleration in speed and distance will
inevitably come a range of new health and healthcare challenges
for the people who move, the people they meet and interact with
along the way, and those they finally settle down with. Few of
these coming challenges are likely to be impossible for countries
or the international community to manage, but all of them will
call for a type of epidemiological vigilance and healthcare services
preparedness that is still lacking today in many countries and
regions of the world.
Thus far the world has seen fit to adopt the International Health
Regulations (IHR) which bind 194 signature countries to work
together in responding to global epidemic threats and doing so in
ways that respect human rights while protecting the health and
wellbeing of the many, and avoiding undue chaos in international
trade and travel circles. For IHR to be effective, it means that
countries need to align their surveillance and reporting, be able and
willing to respond quickly and transparently to suspect outbreaks,
and be open to exchanging specialists as well as infection data among
themselves and with WHO. The emergence of a new coronavirus in
Wuhan, China has precipitated the type of rapid and coordinated
response that will hopefully lead to a rapid characterization of the
virus, its modes of transmission and how it must be managed.
Preparing for future events of this kind is important, because
there will inevitably be many more. The size of our cities, the ways
in which we live, the extent to which we move, and the speed with
which we expect to move will produce new risk configurations.
Identifying these early and modelling the ways in which new
diseases might spread is essential. Training medical staff to identify,
report and respond to them is equally important. New screening
technologies and isolation principles will have to be developed, and
creative public information systems put in place to inform without
causing unwarranted panic, and generate cooperation without
forcing. Above all, it will be necessary to strengthen global reporting
mechanisms and the national and international organizations that
will be called on to manage future outbreaks. In a global village,
moreover, it will be essential that we have a universally agreedupon
health center of excellence to guide the response to health
emergencies. If WHO is to continue performing this role, it must be
given the means to do so.
Bio chemistry
University of Texas Medical Branch, USADepartment of Criminal Justice
Liberty University, USADepartment of Psychiatry
University of Kentucky, USADepartment of Medicine
Gally International Biomedical Research & Consulting LLC, USADepartment of Urbanisation and Agricultural
Montreal university, USAOral & Maxillofacial Pathology
New York University, USAGastroenterology and Hepatology
University of Alabama, UKDepartment of Medicine
Universities of Bradford, UKOncology
Circulogene Theranostics, EnglandRadiation Chemistry
National University of Mexico, USAAnalytical Chemistry
Wentworth Institute of Technology, USAMinimally Invasive Surgery
Mercer University school of Medicine, USAPediatric Dentistry
University of Athens , GreeceThe annual scholar awards from Lupine Publishers honor a selected number Read More...